Virtus ETF Advisers LLC Amgen Inc Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Amgen Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,276 shares of AMGN stock, worth $371,520. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,276

Previous 1,103 15.68%

Holding current value

$371,520

Previous $355,000 6.48%

% of portfolio

0.14%

Previous 0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $44,768 - $56,797	173 Added 15.68%	1,276 $332,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $73,044 - $88,768	-278 Reduced 20.13%	1,103 $344,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $53,774 - $64,912	200 Added 16.93%	1,381 $392,000
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $50,628 - $57,115	-198 Reduced 14.36%	1,181 $340,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $36,514 - $45,333	-167 Reduced 10.8%	1,379 $370,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $85,279 - $100,841	398 Added 34.67%	1,546 $343,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $7,225 - $8,806	32 Added 2.87%	1,148 $277,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $26,338 - $33,466	115 Added 11.49%	1,116 $293,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3,591 - $4,050	16 Added 1.62%	1,001 $226,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $174,186 - $193,838	-755 Reduced 43.39%	985 $240,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $30,030 - $34,367	-151 Reduced 7.99%	1,740 $391,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $37,996 - $44,517	-179 Reduced 8.65%	1,891 $402,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $158,834 - $176,215	-680 Reduced 24.73%	2,070 $505,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $21,747 - $25,342	98 Added 3.7%	2,750 $684,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $6,707 - $7,987	-31 Reduced 1.16%	2,652 $610,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $53,265 - $59,235	227 Added 9.24%	2,683 $682,000
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $6,527 - $8,010	-33 Reduced 1.33%	2,456 $579,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $38,270 - $50,757	-210 Reduced 7.78%	2,489 $505,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $234,620 - $301,568	-1,240 Reduced 31.48%	2,699 $651,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $114,564 - $137,271	-658 Reduced 14.31%	3,939 $762,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $766,319 - $898,299	4,597 New	4,597 $847,000

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Amgen Inc Transaction History